V P Gotz - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

V P Gotz

Showing results (31-40 of 33) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 33 results.

Therapeutic Drug Monitoring|September 1, 1987

Serum lidocaine concentrations following application to the oropharynx: effects of cimetidineR C Parish, V P Gotz, L M Lopez, et al.

Transplantation Proceedings|April 26, 2005

Daclizumab is associated with decreased rejection and no increased mortality in cardiac transplant patients receiving MMF, cyclosporine, and corticosteroidsJ Kobashigawa, K David, J Morris, et al.

Clinical Transplantation|May 10, 2005

Daclizumab is associated with decreased rejection and improved patient survival in renal transplant recipientsJ A Morris, J E Hanson, B J Steffen, et al.

Pageof 4

Search research articles

Showing results (31-40 of 33) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 33 results.

Therapeutic Drug Monitoring|September 1, 1987

Serum lidocaine concentrations following application to the oropharynx: effects of cimetidineR C Parish, V P Gotz, L M Lopez, et al.

Transplantation Proceedings|April 26, 2005

Daclizumab is associated with decreased rejection and no increased mortality in cardiac transplant patients receiving MMF, cyclosporine, and corticosteroidsJ Kobashigawa, K David, J Morris, et al.

Clinical Transplantation|May 10, 2005

Daclizumab is associated with decreased rejection and improved patient survival in renal transplant recipientsJ A Morris, J E Hanson, B J Steffen, et al.

Pageof 4